Tags

Type your tag names separated by a space and hit enter

Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type I) diabetics.
Exp Clin Endocrinol. 1984 Apr; 83(2):136-42.EC

Abstract

10 labile insulin-dependent diabetic patients treated with CSII were followed up for 6 to 16 months under conditions of everyday life. The mean blood glucose (MBG), glycosylated haemoglobin (HbA1), motor nerve conduction velocity (MCV), and respiratory heart arrhythmia at rest (RHA) were investigated. A significant improvement of metabolic control was observed (MBG 8.03 +/- 1.40 vs 5.18 +/- 0.87 mmol/l, p less than 0.01; HbA1 10.7 +/- 1.3 vs 8.7 +/- 1.6%, p less than 0.05) in comparison with the control values under intensified conventional therapy. MCV increased gradually but the average RHA remained unchanged. The psychological examination employing a questionnaire reflects that all patients selected were highly motivated and that their positive attitudes were further stabilized during pump treatment. An average of three mild hypoglycaemic episodes occurred per month per patient; these were no more than under intensified conventional treatment. Other minor clinical and technical complications occurred at a total frequency of one per month per patient and did not achieve therapeutical relevance.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

6373315

Citation

Felsing, W, et al. "Results of Treatment With Continuous Subcutaneous Insulin Infusion (CSII) in Insulin-dependent (type I) Diabetics." Experimental and Clinical Endocrinology, vol. 83, no. 2, 1984, pp. 136-42.
Felsing W, Bibergeil H, Menzel R, et al. Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type I) diabetics. Exp Clin Endocrinol. 1984;83(2):136-42.
Felsing, W., Bibergeil, H., Menzel, R., Albrecht, G., Felsing, U., Dabels, J., Reichel, G., & Lüder, C. (1984). Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type I) diabetics. Experimental and Clinical Endocrinology, 83(2), 136-42.
Felsing W, et al. Results of Treatment With Continuous Subcutaneous Insulin Infusion (CSII) in Insulin-dependent (type I) Diabetics. Exp Clin Endocrinol. 1984;83(2):136-42. PubMed PMID: 6373315.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type I) diabetics. AU - Felsing,W, AU - Bibergeil,H, AU - Menzel,R, AU - Albrecht,G, AU - Felsing,U, AU - Dabels,J, AU - Reichel,G, AU - Lüder,C, PY - 1984/4/1/pubmed PY - 1984/4/1/medline PY - 1984/4/1/entrez SP - 136 EP - 42 JF - Experimental and clinical endocrinology JO - Exp Clin Endocrinol VL - 83 IS - 2 N2 - 10 labile insulin-dependent diabetic patients treated with CSII were followed up for 6 to 16 months under conditions of everyday life. The mean blood glucose (MBG), glycosylated haemoglobin (HbA1), motor nerve conduction velocity (MCV), and respiratory heart arrhythmia at rest (RHA) were investigated. A significant improvement of metabolic control was observed (MBG 8.03 +/- 1.40 vs 5.18 +/- 0.87 mmol/l, p less than 0.01; HbA1 10.7 +/- 1.3 vs 8.7 +/- 1.6%, p less than 0.05) in comparison with the control values under intensified conventional therapy. MCV increased gradually but the average RHA remained unchanged. The psychological examination employing a questionnaire reflects that all patients selected were highly motivated and that their positive attitudes were further stabilized during pump treatment. An average of three mild hypoglycaemic episodes occurred per month per patient; these were no more than under intensified conventional treatment. Other minor clinical and technical complications occurred at a total frequency of one per month per patient and did not achieve therapeutical relevance. SN - 0232-7384 UR - https://www.unboundmedicine.com/medline/citation/6373315/Results_of_treatment_with_continuous_subcutaneous_insulin_infusion__CSII__in_insulin_dependent__type_I__diabetics_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-0029-1210322 DB - PRIME DP - Unbound Medicine ER -